Abstract
Department of Microbiology and Molecular Genetics, University of California, Los Angeles 90095-1679, USA.
Familial combined hyperlipidemia (FCHL) is a complex genetic disorder of unknown etiology. Recently, 'modifier' genes of the FCHL phenotype, such as the apolipoprotein AI-CIII-AIV gene cluster and LPL, have been identified in several populations. A 'major' gene for FCHL has been identified in a Finnish isolate which maps to a region syntenic to murine chromosome 3 where a locus for combined hyperlipidemia has been identified. We review these and other recent studies which indicate that FCHL is genetically heterogeneous.
Publication Types:
Review
Review, Tutorial
Familial combined hyperlipidemia (FCHL) is a complex genetic disorder of unknown etiology. Recently, 'modifier' genes of the FCHL phenotype, such as the apolipoprotein AI-CIII-AIV gene cluster and LPL, have been identified in several populations. A 'major' gene for FCHL has been identified in a Finnish isolate which maps to a region syntenic to murine chromosome 3 where a locus for combined hyperlipidemia has been identified. We review these and other recent studies which indicate that FCHL is genetically heterogeneous.
Publication Types:
Review
Review, Tutorial
Original language | English |
---|---|
Pages (from-to) | 113-122 |
Number of pages | 10 |
Journal | Current Opinion in Lipidology |
Volume | 10 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1 Jan 1999 |